China Interventional Cardiology Market Outlook to 2033 - Coronary Stents, PTCA Balloon Catheters, Transcatheter Accessories and Others

Description

GlobalData's "China Interventional Cardiology Market Outlook to 2033" is a comprehensive databook report, covering key market data on the China Interventional Cardiology market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloon Catheters, Structural Heart Occlusion Devices, Transcatheter Accessories

The China Interventional Cardiology Market report provides key information and data on -

Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
2023 company share and distribution share data for Interventional Cardiology Market.
Global corporate-level profiles of key companies operating within the China Interventional Cardiology Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

China Interventional Cardiology is segmented as follows -

Coronary Stents
Intravascular Ultrasound Systems (IVUS)
PTCA Balloon Catheters
Structural Heart Occlusion Devices
Transcatheter Accessories

Reasons to Buy

China Interventional Cardiology Market report helps you to develop -

Business strategies by identifying the key market segments poised for strong growth in the future.
Market-entry and market expansion strategies.
Design competition strategies by identifying who-stands-where in the market.
Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
Understand the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Product Code: GDME0255CCDB

1 Table of Contents

1.1 List of Tables
1.2 List of Figures

2 Introduction

2.1 What Is This Report About?
2.2 Interventional Cardiology Market Segmentation
2.3 Definitions of Markets Covered in the Report

3 Interventional Cardiology Market, China

3.1 Interventional Cardiology Market, China, Revenue ($m), 2018-2033
- 3.1.1 Coronary Stents Market, China, Revenue ($m), by Segment, 2018-2033
- 3.1.2 Intravascular Ultrasound Systems (IVUS) Market, China, Revenue ($m), by Segment, 2018-2033
- 3.1.3 PTCA Balloon Catheters Market, China, Revenue ($m), by Segment, 2018-2033
- 3.1.4 Structural Heart Occlusion Devices Market, China, Revenue ($m), by Segment, 2018-2033
- 3.1.5 Transcatheter Accessories Market, China, Revenue ($m), by Segment, 2018-2033
3.2 Interventional Cardiology Market, China, Volume (Units), 2018-2033
- 3.2.1 Coronary Stents Market, China, Volume (Units), by Segment, 2018-2033
- 3.2.2 Intravascular Ultrasound Systems (IVUS) Market, China, Volume (Units), by Segment, 2018-2033
- 3.2.3 PTCA Balloon Catheters Market, China, Volume (Units), by Segment, 2018-2033
- 3.2.4 Structural Heart Occlusion Devices Market, China, Volume (Units), by Segment, 2018-2033
- 3.2.5 Transcatheter Accessories Market, China, Volume (Units), by Segment, 2018-2033
3.3 Interventional Cardiology Market, China, Average Price ($) , 2018-2033
3.4 Interventional Cardiology Market, China, Distribution Share by Revenue ($m), 2023
3.5 Interventional Cardiology Market, China, Company Share by Revenue ($m), 2023

4 Overview of Key Companies in China, Interventional Cardiology Market

4.1 Abbott Laboratories
- 4.1.1 Company Overview
4.2 Boston Scientific Corp
- 4.2.1 Company Overview
4.3 Terumo Corp
- 4.3.1 Company Overview
4.4 Koninklijke Philips NV
- 4.4.1 Company Overview
4.5 Asahi Intecc Co Ltd
- 4.5.1 Company Overview
4.6 Medtronic Plc
- 4.6.1 Company Overview
4.7 AtriCure Inc
- 4.7.1 Company Overview
4.8 B. Braun Melsungen AG
- 4.8.1 Company Overview
4.9 Lepu Medical Technology (Beijing) Co Ltd
- 4.9.1 Company Overview
4.10 MicroPort Scientific Corp
- 4.10.1 Company Overview
4.11 Shockwave Medical Inc
- 4.11.1 Company Overview
4.12 W. L. Gore & Associates Inc
- 4.12.1 Company Overview
4.13 Teleflex Inc
- 4.13.1 Company Overview
4.14 Biotronik SE & Co KG
- 4.14.1 Company Overview

5 Interventional Cardiology Market Pipeline Products

6 Financial Deals Landscape

6.1 Acquisition
- 6.1.1 Shenzhen Mindray Scientific Plans to Acquire 21.2% Stake in APT Medical for USD936.32 Million
6.2 Debt Offerings
- 6.2.1 MicroPort Scientific to Raise USD220 Million in Public Offering of 5.75% Convertible Bonds Due 2028
6.3 Venture Financing
- 6.3.1 Tianjin Hengyu Medical Technology Secures Venture Financing
- 6.3.2 Tianjin Hengyu Medical Technology (Hori Medcare, Tianjin Hori Medical) Secures Series D Funding
- 6.3.3 Shenyang Shenda Endoscope Raises Funds through Series C Financing
- 6.3.4 Shaoxing Mayo Magnetic Medical Technology Raises Funds through Series A+ Financing
- 6.3.5 Tianjin Hengyu Medical Technology (Hori Medcare, Tianjin Hori Medical) Secures Additional USD13.94 Million in Series C+ Funding

7 Recent Developments

7.1 Corporate Communications
- 7.1.1 Nov 10, 2023: Microport Appointment of Director
7.2 Financial Announcements
- 7.2.1 Jun 17, 2024: Peijia Medical Reports Audited 2023 Financial Results and Resumes Trading
- 7.2.2 Sep 21, 2023: Microport Scientific Corp. Announces 2023 Interim Report
- 7.2.3 Aug 31, 2023: Peijia Medical Announces 2023 Interim Results
7.3 Legal And Regulatory
- 7.3.1 Jun 20, 2023: Shenzhen Mindray Bio-Medical Electronics Receives an Additional 510(k) Clearance for M8 Elite Diagnostic Ultrasound System
7.4 Strategy And Business Planning
- 7.4.1 Jun 20, 2023: Shenzhen Mindray Bio-Medical Electronics Receives an Additional 510(k) Clearance for M11 Diagnostic Ultrasound System

8 Appendix

8.1 Research Methodology
- 8.1.1 Coverage
- 8.1.2 Secondary Research
- 8.1.3 Primary Research
- 8.1.4 Market Modeling and Forecasting
- 8.1.5 Company Share Analysis
- 8.1.6 Distribution Share Analysis
- 8.1.7 Benchmarking
8.2 GlobalData Consulting
8.3 Contact Us
8.4 Disclaimer